SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0001387131-10-000744
Filing Date
2010-07-14
Accepted
2010-07-14 17:30:55
Documents
8
Period of Report
2010-03-31

Document Format Files

Seq Description Document Type Size
1 ANNUAL REPORT adamis-10k_0713.htm 10-K 1730543
2 STOCK ACQUISITION AGREEMENT ex-10_31.htm EX-10.31 130824
3 SUBSIDIARIES OF ADAMIS ex-21.htm EX-21 5620
4 302 CERTIFICATION OF CEO ex-31_1.htm EX-31.1 14928
5 302 CERTIFICATION OF CFO ex-31_2.htm EX-31.2 14813
6 906 CERTIFICATION OF CEO ex-32_1.htm EX-32.1 7170
7 906 CERTIFICATION OF CFO ex-32_2.htm EX-32.2 7420
8 adamis-10k_07130.jpg GRAPHIC 7376
  Complete submission text file 0001387131-10-000744.txt   1922738
Mailing Address 2658 DEL MAR HEIGHTS RD #555 DEL MAR CA 92014
Business Address 2658 DEL MAR HEIGHTS RD #555 DEL MAR CA 92014 (858) 401-3984
Adamis Pharmaceuticals Corp (Filer) CIK: 0000887247 (see all company filings)

IRS No.: 820429727 | State of Incorp.: DE | Fiscal Year End: 0331
Type: 10-K | Act: 34 | File No.: 000-26372 | Film No.: 10952838
SIC: 2834 Pharmaceutical Preparations